{4-[5-(3-chloro-phenoxy)-oxazolo[5,4 d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid for use in the prevention or treatment of acute kidney injury

  • Application ID: EP13306417
  • Status: █ APPLICATION DEEMED TO BE WITHDRAWN

Applicant

Technology company logo small
Sanofi, S.A.
Technology Company

Attorney

Missing person image small
Marie Catillon
no operation time available
Sanofi
2 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Sanofi is specialized in A61. Sanofi is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 22.04.2015 - Publication A1 (EP2862574)

IPC Classification